US$ 24.19
glp-1 and colonoscopy Receptor Agonists: Benefits Risks in Colorectal Cancer GIs clash with GLP-1 restrictions
Description
Before starting, check in with your doctor to make sure its right for you

Studies done on obese mice show that GIP may help burn more energy and reduce fat build-up
That can be used as a useful guide to alert one to take action. Dont stop with weight, though

[1] Long-term treatment (beyond 812 weeks): For the majority of patients who continue Ozempic, gastrointestinal side effects gradually diminish over time as physiological adaptation occurs

Patients with Type 2 diabetes who received GLP-1RAs had an increased risk of gastroparesis diagnosis at six, nine, 12, 18 and 24 months

While clinical trials show an average weight loss of 10.2%, in reality, some people lose over 25% of their body weight, while 32.2% lose less than 5% or even gain weight
